CD155 Expression Predicts Poor Prognosis in OTSCC and Correlates With TIGIT Expression and Tumor Budding. Kimura S, Aoki M, Nishi K, Takeuchi T, et al. Anticancer Res 2025;45:3511-3522.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kimura S, Aoki M, Nishi K, Takeuchi T, et al. CD155 Expression Predicts Poor Prognosis in OTSCC and Correlates With TIGIT Expression and Tumor Budding. Anticancer Res 2025;45:3511-3522.
PMID: 40750415